The molecular genetics of post-transplantation lymphoproliferative disorders

Adldinger HK, Delius H, Freese UK, Clarke J, Bomkamm GW (1985) A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:221 Baron BW, Nucifora G, McNabe N, Espinosa RI, LeBeau M, McKeithan TW (1993) Identification of the gene associated with the recurring chromosomal translocations t(3;14)(g27;q32) and t(3;22)(g27;q11) in B-cell lymphomas. Proc Natl Acad Sci USA 90:5262 Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, Fruchart C, Duval C, Monconduit M, Tilly H (1994) LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 83:2423 Borisch B, Finke J, Hening I, Delacretaz F, Schneider J, Heitz PU, Laissue JA (1992) Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 168:229 Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA (1991) Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin's lymphoma. Blood 78:3004 Cattoretti G, Chang CC, Cechova K, Zhang J, Ye BH, Falini B, Louis DC, Offit K, Chaganti RS, Dalla-Favera R (1995) BCL-6 protein is expressed in germinal center B cells. Blood 86:45 Cesarman E, Chadburn A, Liu YF Migliazza A, Dalla-Favera R, Knowles DM (1998) BCL-6 gene mutations in post-transplantation lymphoproliferative disorders (PT LPDs) as predictors of response to therapy and clinical outcome. Blood (in press) Chadburn A, Cesarman E, Liu YF, Addonizio L, Hsu D, Michler RE, Knowles DM (1995) Molecular genetic analysis demonstrates that multiple post-transplantation lymphoproliferative disorders occurring in one anatomic site in a single patient represent distinct primary lymphoid neoplasms. Cancer 75:2747 Chadbum A, Cesarman E, Knowles DM (1997) Molecular pathology of the post-transplantation lymphoproliferative disorders. Semin Diagn Pathol 14:15 Chadburn A, Chen JM, Hsu DT, Frizzera G, Cesarman E, Garrett TJ, Mears JG, Zangwill S, Addonizio LJ, Michler RE, Knowles DM (1998) The morphologic and molecular genetic classification of posttransplantation lymphoproliferative disorders (PT-LPDs) has clinical relevance. Cancer 82: 1978 Chang CC, Ye BH, Chaganti RS, Dalla-Favera R (1996) BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 93:6947 Cleary ML, Sklar J (1984) Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet 11:489 Cleary ML, Warnke R, Sklar J (1984) Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: Conal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 310:477 Cleary ML, Nalesnik MA, Shearer WT, Sklar J (1988) Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 72:349 Dambaugh T, Hennessy K, Chamnankit L, Kieff E (1984) U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 81:7632 Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM (1997) Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276:589 Deweindt C, Kerckaert JP, Tilly H, Quief S, Nguyen VC, Bastard C (1993) Cloning of a breakpoint cluster region at band 3827 involved in human non-Hodgkin's lymphoma. Genes Chromosomes Cancer 8:149 Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D (1995) The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Cell Growth Differ 6:1495 Fennewald S, Santen V van, Kieff E (1984) Nucleotide sequence of a mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51:411 Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL (1989) Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mod Pathol 2:583 Frank D, Cesannan E, Liu YF, Michler RE, Knowles DM (1995) Post-transplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396 Frizzera G (1992) Atypical lymphoproliferative disorders. In: Knowles DM (ed) Neoplastic hematopathology. Williams & Wilkins, Baltimore, pp 459–495 Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL (1981) Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 41:4262 Gaidano G, Dalla-Favera R (1992) Protooncogenes and tumor suppressor genes. In Knowles DM (ed) Neoplastic hematopathology. Williams & Wilkins, Baltimore, pp 245–261 Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine A, Knowles DM, Dalla-Favera R (1994) Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma: association with diffuse large-cell subtype. Blood 15:397 Gaidano G, Carbone A, Pastore C, Capello D, Migliazza A, Gloghini A, Roncella S, Ferrarini M, Saglio G, Dalla-Favera R (1997) Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood 89:3755 Hanto DW, Gaji-Peczalsak KJ, Frizzera G, Arthur DC, Balfour HH Jr, McClain K, Simmons RL, Najarian JS (1983) Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymph oproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 198:356 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361 Hu LF, Zabarovsky ER, Chen F, Cao SL, Emberg I, Klein G, Winberg G (1991) Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399 Kaplan MA, Ferry JA, Harris NL, Jacobson JO (1994) Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am J Clin Pathol 101:590 Kerckaert J-P, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C (1993) LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3g27 translocations in human lymphoma. Nat Genet 5:66 Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M (1996) Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242 Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G (1993) Deletions within the LMP1 oncogene of Epstein- Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937 Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 85:552 Kuppers R, Zhao M, Hausmann ML, Rajewsky K (1993) Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J 12:4955 Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB (1992) Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. AIDS Res Hum Retroviruses 8:1869 Lager DJ, Burgart LJ, Slagel DD (1993) Epstein-Barr virus detection in sequential biopsies from patients with a posttransplantation lymphoproliferative disorder. Mod Pathol 6:42 Locker J, Nalesnik M (1989) Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977 Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, Chaganti RS, Dalla-Favera R (1994) Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83:1757 McKhann CF (1969) Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 8:209 Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RSK, Dalla-Favera R (1995) Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 92:12520 Miki T, Kawamata N, Hirosawa S, Aoki N (1994) Gene involved in the 3827 translocation associated with B-cell lymphoma, BCL5, encodes a Krüpel-like zinc- finger protein. Blood 83:26 Miklos JA, Locker J, Bahler DW (1995) Evidence for antigen selection in posttransplant lymphoproliferative disorders. Lab Invest 72:116A Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J (1988) The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 133:173 Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas (1982) Summary and description of a working formulation for clinical usage. Cancer 49:2112 Otsuki T, Yano T, Clark HM, Bastard C, Kerckaert JP, Jaffe ES, Raffeld M (1995) Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 85:2877 Penn I (1978) Malignancies associated with immunosuppressioe or cytotoxic therapy. Surgery 83:492 Penn I (1991) The changing pattern of posttransplant malignancies. Transplant Proc 23:1101 Penn I, Hammon W, Brettschneider L, Starzl TE (1969) Malignant lymphomas in transplantation patients. Transplant Proc 1:106 Randhawa PS, Yousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J (1989) The clinical spectrum, pathology and clonal analysis of Epstein-Barr virus-associated lymphoproliferative disorders in heartlung transplant recipients. Am J Clin Pathol 92:177 Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM (1992) Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with posttransplantation lymphoproliferative disease. N Engl J Med 327:1710 Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310 Riddler SA, Breining MC, McKnight JLC (1994) Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:972 Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084 Scheinfeld AG, Nader RG, Cesarman E, Chadburn, A, Knowles DM (1997) Epstein-Barr virus latent membrane protein-I oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol 151:805 Sculley TB, Cross SM, Borrow P, Cooper DA (1988) Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus. J Infect Dis 158:186 Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA (1990) Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643 Seyfert VL, Allman D, He YS, Staudt LM (1996) Transcriptional repression by the proto-oncogene BCL-6. Oncogene 12:2331 Shearer WT, Ritz J, Finegold MJ, Guerra IC, Rosenblatt HM, Lewis DE, Pollack MS, Taber LH, Sumaya CV, Grumet FC, Cleary ML, Warnke R, Sklar J (1985) Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 312:1151 Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet 11:761 Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL, Atchison RW, Jaffe R, Bahnson HT (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583 Swinnen LJ, Costanzo-Nordin MR, Fisher SG, O'Sullivan EJ, Johnson MR, Heroux AL, Dizikes GJ, Pifare R, Fisher RI (1990) Increased incidence of lymphoproliferative disorders after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323:1723 Wang D, Liebowitz D, Kieff E (1995) An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831 Wilkinson AH, Smith JL, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Cory RJ (1989) Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation 47:293 Ye BH, Lista F, Lo Coco F, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R (1993) Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 262:747 Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS, Dalla-Favera R (1995) Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14:6209 Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, Waard R de, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RSK, Rothman P, Stall AM, Pandolfi P-P, Dalla-Favera R (1997) The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 16:161 Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB (1987) New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68:2853 Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Bornkamm GW (1986) Geographical prevalence of two types of Epstein-Bar virus. Virology 154:56